Identification and Characterization of an Epigenetic Program that Maintains the Self-Renewal of MLL Myeloid Leukemia Stem Cells |
Stanford University / Hon-Kit Wong |
Young Investigator Grants |
2010 |
California |
Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG |
Lucile Packard Children’s Hospital at Stanford University School of Medicine / Yujie Tang, PhD |
Young Investigator Grants |
2014 |
California |
An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas |
Cedars-Sinai Medical Center / Sandra Orsulic, PhD |
Innovation Grants |
2013 |
California |
Activation of Anti-Leukemia Immunity by Targeting Protein Arginine Methyltransferase |
City of Hope National Medical Center / Ling Li, PhD |
R Accelerated Award Grants |
2023 |
California |
Single-cell RNA-seq Profiling of Transcriptional Transition States During Human Retinoblastoma |
Children’s Hospital Los Angeles / Sunhye Lee, PhD |
Young Investigator Grants |
2016 |
California |
Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias |
University of California at Santa Cruz / Camilla Forsberg, PhD |
Innovation Grants |
2013 |
California |
Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma |
The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D. |
Reach Grants |
2014 |
California |
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD |
Innovation Grants |
2015 |
California |
Modeling osteosarcoma to identify novel therapeutic targets.
|
Stanford University / Julien Sage |
Young Investigator Grants |
2006 |
California |
Single Cell Signaling Profiles In High-Risk Pediatric Leukemia |
Stanford University / Kara Davis |
Young Investigator Grants |
2010 |
California |